MULTIVALENT PEPTIDOMIMETIC CONJUGATES AS INHIBITORS OF ANDROGEN RECEPTOR FUNCTION IN THERAPY-RESISTANT PROSTATE CANCER
$496,662FY2015Department of DefenseDOD
New York University, New York NY
Investigators
View source on USAspending →MULTIVALENT PEPTIDOMIMETIC CONJUGATES AS INHIBITORS OF ANDROGEN RECEPTOR FUNCTION IN THERAPY-RESISTANT PROSTATE CANCER · GrantIndex